Skip to content
The Nexus
HEALTHMay 28 · 10:45 UTCCNBC TOP

CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans

CVS Health will add Zepbound coverage starting October 1 and begin covering Eli Lilly's newly approved obesity treatment, Foundayo, on June 1. The moves expand drug plan accessibility for weight management medications.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
CVS HealthorganizationEli Lilly and CompanyorganizationZepboundtopicFoundayotopicObesitytopicDrug Coveragetopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting